drug

Blood tests

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
PROCEDURE
Pre-approval / investigational in the US
Developed by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
PROCEDURE

Indications

Trials

1
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
NCT00159770Phase 3Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
company
trial
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
PHASE3
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Psychotic Disorders
indication